TigerText Introduces First Secure Enterprise Messaging App for the Apple Watch TigerText’s Apple Watch app enables enterprises to work securely – directly from their wrists Santa Monica, CA (April 14, 2015) – TigerText, a provider of secure, real-time messaging for...
Dimension Therapeutics Secures $65 Million in Oversubscribed Series B Financing Dimension Is Advancing Liver-Directed Gene Therapy Treatments for Rare Metabolic Disorders and Hemophilia Based on Innovative AAV technologies and a Proprietary Manufacturing Platform...
Edge Therapeutics Completes Enrollment in Phase 1/2 NEWTON Study of EG-1962 for Patients with Ruptured Brain Aneurysm Favorable Outcomes Reported in 67% of EG-1962 Treated Patients at Study Mid-point BERKELEY HEIGHTS, N.J.– May 28, 2015 — Edge Therapeutics...
VaxInnate Advances Quadrivalent Seasonal Influenza Vaccine Candidate, VAX2012Q, into Phase 2 Study Top-line results expected in second half of 2015 Cranbury, NJ, June 3, 2015 – VaxInnate Corporation, a biotechnology firm pioneering a breakthrough vaccine technology...
Spiracur Expands Global Reach with the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System New Clinical Data Reaffirms Better Wound Healing, Cost Savings and Improved Patient Quality of Life with Spiracur’s Smart Negative...
Spiracur Expands Global Reach with the Release of New International Clinical Data and the Introduction of the SNaP Plus Therapy System New Clinical Data Reaffirms Better Wound Healing, Cost Savings and Improved Patient Quality of Life with Spiracur’s Smart Negative...
Recent Comments